Demo Patient View
This is a demo page intro. This study is made up and not really active.
... minute read
sponsor
This is a demo page intro. This study is made up and not really active.
Choose your location
Contact
Contact
Tulisokibart is a potential treatment developed to manage active, moderate to severe UC. Researchers aim to determine how well this treatment works and whether more people receiving the medication experience symptom relief compared to those receiving a placebo. A placebo contains no active substance. The use of a placebo helps researchers better understand the effectiveness of the new treatment.
Ulcerative Colitis (UC)
UC is an inflammatory bowel disease (IBD) that causes swelling and ulcers in the digestive tract. It affects the lining of the colon, including the rectum. People with ulcerative colitis often experience periods with few or no symptoms, followed by periods of symptom flare-ups. The disease is rarely life-threatening but can have a significant impact on quality of life. Therefore, finding effective treatment options is important.
Participants will receive one or both of the following treatments:
Both the active drug and placebo will be administered:
These questions are here to help you determine if you might be eligible for this trial, but it is not conclusive. If you are ever in doubt, please refer to your health care professional.
Contact this trial today!
Have questions about our clinical trials or need more information on how to participate? Our team is here to provide you with all the details you need. Don’t hesitate to reach out to us today!
Clients can author custom commonly asked questions as they pertain to the specific study in structured and easy to digest manner.
What is the purpose of this clinical trial?
Who can participate in the trial?
Prof. PhD. ATLAS-UC Research Lead
Dr. Jane Smith, is a gastroenterologist specializing in Ulcerative Colitis (UC) and inflammatory bowel diseases. With a passion for patient-centered care and cutting-edge research, Dr. Smith focuses on advancing treatments to improve the quality of life for those with UC.
Helpful Information
Brochure name
Knowledge
UK patient association
https://crohnsandcolitis.org.uk/Every day, people are diagnosed with Crohn's or Colitis, the two main forms of inflammatory bowel disease. You could be any age, rich or poor, of any faith or none, of any ethnicity, sexuality, or gender. You could be anyone walking down any UK street. Whoever you are, a diagnosis of Crohn's or Colitis will be life changing.
Regulatory approval
Link:
https://www.nhs.ukThank you for exploring our trial!
We appreciate you taking the time to learn more. How can we assist you next?
Share this trial
Share this trial with someone who might find it helpful.
Contact the trial team
Let us know if you're interested in participating in this trial.
Download Page
Get a printable version to read later or share with your doctor.